JP2014520886A5 - - Google Patents

Download PDF

Info

Publication number
JP2014520886A5
JP2014520886A5 JP2014521705A JP2014521705A JP2014520886A5 JP 2014520886 A5 JP2014520886 A5 JP 2014520886A5 JP 2014521705 A JP2014521705 A JP 2014521705A JP 2014521705 A JP2014521705 A JP 2014521705A JP 2014520886 A5 JP2014520886 A5 JP 2014520886A5
Authority
JP
Japan
Prior art keywords
het
atoms
physiologically acceptable
compound according
hal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014521705A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014520886A (ja
JP6162694B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/047038 external-priority patent/WO2013012848A1/en
Publication of JP2014520886A publication Critical patent/JP2014520886A/ja
Publication of JP2014520886A5 publication Critical patent/JP2014520886A5/ja
Application granted granted Critical
Publication of JP6162694B2 publication Critical patent/JP6162694B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014521705A 2011-07-18 2012-07-17 ベンズアミド類 Expired - Fee Related JP6162694B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161508861P 2011-07-18 2011-07-18
US61/508,861 2011-07-18
US201161526342P 2011-08-23 2011-08-23
US61/526,342 2011-08-23
PCT/US2012/047038 WO2013012848A1 (en) 2011-07-18 2012-07-17 Benzamides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017043934A Division JP6254730B2 (ja) 2011-07-18 2017-03-08 ベンズアミド類

Publications (3)

Publication Number Publication Date
JP2014520886A JP2014520886A (ja) 2014-08-25
JP2014520886A5 true JP2014520886A5 (https=) 2017-06-15
JP6162694B2 JP6162694B2 (ja) 2017-07-12

Family

ID=46551951

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014521705A Expired - Fee Related JP6162694B2 (ja) 2011-07-18 2012-07-17 ベンズアミド類
JP2017043934A Expired - Fee Related JP6254730B2 (ja) 2011-07-18 2017-03-08 ベンズアミド類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017043934A Expired - Fee Related JP6254730B2 (ja) 2011-07-18 2017-03-08 ベンズアミド類

Country Status (9)

Country Link
US (3) US9181226B2 (https=)
EP (2) EP2734517B1 (https=)
JP (2) JP6162694B2 (https=)
CN (1) CN103702993B (https=)
AU (2) AU2012284184B2 (https=)
CA (1) CA2834199C (https=)
ES (2) ES2649995T3 (https=)
IL (1) IL230463A (https=)
WO (1) WO2013012848A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013012848A1 (en) * 2011-07-18 2013-01-24 Merck Patent Gmbh Benzamides
WO2013106409A1 (en) 2012-01-10 2013-07-18 Merck Patent Gmbh Benzamide derivatives as modulators of the follicle stimulating hormone
CA2914178C (en) 2013-01-07 2023-06-13 University Of Southern California Deoxyuridine triphosphatase inhibitors
AR095202A1 (es) * 2013-03-11 2015-09-30 Merck Patent Gmbh Heterociclos como moduladores de la actividad quinasa
CN104717415B (zh) * 2013-12-12 2019-03-01 华为技术有限公司 一种摄像装置
WO2015196335A1 (en) 2014-06-23 2015-12-30 Tocopherx, Inc. Pyrazole compounds as modulators of fshr and uses thereof
ES2790875T3 (es) * 2014-12-05 2020-10-29 Pulmocide Ltd Compuesto antimicótico
US10544105B2 (en) 2015-07-08 2020-01-28 Cv6 Therapeutics (Ni) Limited Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
WO2017006271A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
WO2017006270A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors
PT3319939T (pt) 2015-07-08 2025-03-05 Cv6 Therapeutics Ni Ltd Inibidores de desoxiuridina-trifosfatase contendo hidantoína
EP3365324A1 (en) 2015-10-22 2018-08-29 The Procter and Gamble Company Synthesis of cyclohexane carboxamide derivatives useful as sensates in consumer products
WO2018098204A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited 6-membered uracil isosteres
US11168059B2 (en) 2016-11-23 2021-11-09 Cv6 Therapeutics (Ni) Limited Amino sulfonyl compounds
US10829457B2 (en) 2016-11-23 2020-11-10 Cv6 Therapeutics (Ni) Limited Nitrogen ring linked deoxyuridine triphosphatase inhibitors
WO2018128720A1 (en) 2017-01-05 2018-07-12 Cv6 Therapeutics (Ni) Limited Uracil containing compounds

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258224A (ja) * 1994-03-24 1995-10-09 Dai Ichi Seiyaku Co Ltd 二環性化合物
JPH0959236A (ja) * 1995-08-23 1997-03-04 Dai Ichi Seiyaku Co Ltd ベンズアミド化合物
WO1997029079A1 (en) * 1996-02-06 1997-08-14 Japan Tobacco Inc. Novel compounds and pharmaceutical use thereof
FR2765221B1 (fr) * 1997-06-25 1999-07-30 Synthelabo Derives de 4-[(1h-imidazol-4-yl)piperidin-1-yl]anilide, leur preparation et leur application en therapeutique
AR013693A1 (es) * 1997-10-23 2001-01-10 Uriach & Cia Sa J Nuevas piperidinas y piperazinas como inhibidores de la agregacion plaquetaria
US6235755B1 (en) 1998-08-07 2001-05-22 Applied Research Systems Ars Holding N.A. FSH mimetics for the treatment of infertility
US7101878B1 (en) * 1998-08-20 2006-09-05 Agouron Pharmaceuticals, Inc. Non-peptide GNRH agents, methods and intermediates for their preparation
AU761453B2 (en) * 1999-03-17 2003-06-05 Astrazeneca Ab Amide derivatives
SE9904652D0 (sv) * 1999-12-17 1999-12-17 Astra Pharma Prod Novel Compounds
EP1307193A1 (en) 2000-07-27 2003-05-07 Affymax Research Institute Agonists of follicle stimulating hormone activity
US20040010033A1 (en) * 2001-02-20 2004-01-15 Pfizer Inc. Non-peptide GnRH agents, methods and intermediates for their preparation
SE0101387D0 (sv) 2001-04-20 2001-04-20 Astrazeneca Ab Novel compounds
WO2003068769A1 (en) * 2002-02-12 2003-08-21 Pfizer Inc. Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
CA2489252A1 (en) * 2002-06-13 2003-12-24 Pfizer Inc. Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
EP1542993B1 (en) * 2002-09-20 2012-12-19 Merck Serono SA Piperazine derivatives and methods of use
SE0203070D0 (en) 2002-10-16 2002-10-16 Astrazeneca Ab Novel compounds
FR2851563B1 (fr) * 2003-02-26 2005-04-22 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
US7700583B2 (en) * 2003-04-11 2010-04-20 High Point Pharmaceuticals, Llc 11β-hydroxysteroid dehydrogenase type 1 active compounds
FR2862971B1 (fr) 2003-11-28 2006-03-24 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament
JPWO2005108370A1 (ja) * 2004-04-16 2008-03-21 味の素株式会社 ベンゼン化合物
WO2006080477A1 (en) 2005-01-25 2006-08-03 Tanabe Seiyaku Co., Ltd. Norvaline derivative and method for preparation thereof
CA2655799A1 (en) * 2005-06-22 2006-12-28 Develogen Aktiengesellschaft Thienopyrimidines for pharmaceutical compositions
WO2007002742A1 (en) * 2005-06-28 2007-01-04 Pharmacopeia, Inc. Substituted [1,4]-diazepanes as cxcr3 antagonists and their use in the treatment of inflammatory disorders
WO2007008541A2 (en) * 2005-07-08 2007-01-18 Kalypsys, Inc. Cellular cholesterol absorption modifiers
EP2407459A1 (en) * 2005-09-27 2012-01-18 Shionogi & Co., Ltd. Synthetic intermediate in the production of a sulfonamide derivative having PGD2 receptor antagonistic activity
CA2651898A1 (en) * 2006-04-07 2007-10-18 Develogen Aktiengesellschaft Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions
WO2007133983A2 (en) * 2006-05-08 2007-11-22 Pharmacopeia, Inc. 2-aminobenzimidazoles for treating neurodegenerative diseases
US20140249135A1 (en) * 2007-03-01 2014-09-04 Novartis Ag Pim kinase inhibitors and methods of their use
CA2679659C (en) 2007-03-01 2016-01-19 Novartis Ag Pim kinase inhibitors and methods of their use
GB0705656D0 (en) * 2007-03-23 2007-05-02 Addex Pharmaceuticals Sa Novel compounds E1
WO2008123469A1 (ja) * 2007-03-30 2008-10-16 Japan Tobacco Inc. ６員環アミド化合物およびその用途
CL2008000986A1 (es) * 2007-04-06 2008-10-17 Neurocrine Biosciences Inc COMPUESTO DERIVADO DE HETEROCICLOS DE NITROGENO, AGONISTAS DEL RECEPTOR GnRH; COMPOSICION FARMACEUTICA QUE COMPRENDE A DICHO COMPUESTO; Y USO PARA TRATAR UNA AFECCION RELACIONADA CON LAS HORMONAS SEXUALES, ENDOMETRIOSIS, DISMENORREA, ENFERMEDAD DE OV
WO2009065596A2 (en) * 2007-11-22 2009-05-28 Develogen Aktiengesellschaft Use of mnk inhibitors for the treatment of alzheimer's disease
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
PE20091576A1 (es) * 2008-02-19 2009-11-05 Sanofi Aventis DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
US20100137386A1 (en) * 2008-12-01 2010-06-03 Tesshi Yamada Tnik inhibitor and the use
US8969342B2 (en) * 2009-03-20 2015-03-03 Brandeis University Compounds and methods for treating mammalian gastrointestinal microbial infections
TWI461426B (zh) 2009-05-27 2014-11-21 Merck Sharp & Dohme （二氫）咪唑並異〔５，１－ａ〕喹啉類
WO2013006308A2 (en) * 2011-07-01 2013-01-10 Merck Patent Gmbh Dihydropyrazoles
WO2013012848A1 (en) * 2011-07-18 2013-01-24 Merck Patent Gmbh Benzamides
WO2013106409A1 (en) * 2012-01-10 2013-07-18 Merck Patent Gmbh Benzamide derivatives as modulators of the follicle stimulating hormone

Similar Documents

Publication Publication Date Title
JP2014520886A5 (https=)
JP6257326B2 (ja) 神経因性疼痛におけるマロノニトリルアミドの使用
JP2021527092A5 (https=)
JP2015529229A5 (https=)
RS53716B1 (sr) Kombinovana terapija kancera sa hsp90 inhibitornim jedinjenjima
JP2016507500A5 (https=)
ES2333805T3 (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
WO2024041330A1 (zh) Ly2922470在制备预防或治疗脑血管疾病或组织缺血再灌注损伤药物中的应用
RU2015134420A (ru) Кристаллические формы { [1-циано-5-(4-хлорофеноксид)-4-гидроксид-изохинолин-3-карбонил]-амино} -уксусной кислоты
KR20200068659A (ko) 3-치환된 1,2,4-옥사다이아졸의 결정질 형태
Liu et al. Protective effects of estrogen combined with sevoflurane in an experimental model of cerebral infarction and focal cerebral ischemia-reperfusion injury.
JP2013500982A (ja) ＰＰＡＲγのベンズイミダゾール誘導体作動薬で神経因性疼痛を治療する方法
WO2018200357A1 (en) Methods and compositions of improving fertility
JP6642892B2 (ja) ジメチルアミノミケリオリドを含む肺線維化の治療薬
JP6960415B2 (ja) 三叉神経痛を予防又は治療する目的のためのカルバメート化合物の使用
ES3054693T3 (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
EA201101622A1 (ru) Пептидная фармацевтическая композиция, средство на ее основе для лечения гастродуоденальных заболеваний, вызываемых helicobacter pylori, и способ его использования
CA2876926C (en) Composition for treating or preventing vascular permeability-related disease containing imatinib or pharmaceutically acceptable salt thereof as active ingredient
JP4927530B2 (ja) エポシロン誘導体および照射による増殖性疾患の処置
CN105078944A (zh) Isopaucifloral F在制备抗骨质疏松药物中的用途
JP2015524460A5 (https=)
JP2012513443A5 (https=)
FI3519050T3 (fi) Koostumuksia silmätautien hoitamiseksi
KR102687556B1 (ko) 종양 전이를 억제하는 방법
CN107427508B (zh) 异喹啉衍生物用于糖尿病伤口愈合的用途